Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure - Trial 2015-003329-32
Access comprehensive clinical trial information for 2015-003329-32 through Pure Global AI's free database. This phase not specified trial is sponsored by Daiichi Sankyo Pharma Development and is currently status unknown. The study focuses on Hypertension.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-003329-32
Trial Details
EU Clinical Trials Register • 2015-003329-32
Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure
Study Focus
Sponsor & Location
Daiichi Sankyo Pharma Development
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1. Had any clinically relevant unstable medical condition or chronic disease other than those associated with hypertension.
ICD-10 Classifications
Hypertensive diseases
Renovascular hypertension
Secondary hypertension
Other secondary hypertension
Hypertensive heart disease
Data Source
EU Clinical Trials Register
2015-003329-32
Non-Device Trial